QUETMOLIMAB
UNII G8NT4Q571B

Substance Identification & Data

This profile provides standardized clinical and technical data for Quetmolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G8NT4Q571B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2084037-83-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G8NT4Q571B

CAS Registry Number

2084037-83-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

QUETMOLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C170361

National Cancer Institute reference terminology for clinical and research data.

INN ID

11040

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-127

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Quetmolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

QUETMOLIMAB

Common Names & Synonyms

E6011, ANTI-CX3CL1 HUMANIZED IGG2, IN CHOK1SV (CHO CELL LINE)

QUETMOLIMAB [INN]

QUETMOLIMAB [USAN]

QUETMOLIMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G2, ANTI-(HUMAN FRACTALKINE) (HUMANIZED MONOCLONAL E6011 .GAMMA.2-CHAIN), DISULFIDE WITH HUMANIZED MONOCONAL E6011 .KAPPA.-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS CX3CL1 (CHEMOKINE CX3-C MOTIF LIGAND 1, SCYD1, SMALL INDUCIBLE CYTOKINE SUBFAMILY D CYS-X3-CYSMEMBER 1, FRACTALKINE, FKN, NEUROTACTIN, NTN)), MONOCLONAL ANTIBODYGAMMA2 HEAVY CHAIN (1-445) (VH (MUS MUSCULUS IGHV1S56*01 (80.4%)-(IGHD)-IGHJ2*01 (93.3%)/HOMO SAPIENS IGHV1-46*01 (76.3%)-(IGHD)-IGHJ4*01 (93.3%)) (8.8.12) (1-119)-HOMO SAPIENS IGHG2*01 (CH1 (120-217), HINGE (218-229), CH2 V1.2>A (233), G1>A (235) (230-338), CH3 (339-443), CHS (444-445)) (120-445)), (133-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-NL1*01 (85.3%)-IGKJ4*01 (100%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (221-221'':222-222'':225-225'':228-228'')-TETRAKISDISULFIDE

SYS